Page last updated: 2024-10-15

arachidonoylcholine

Description

arachidonoylcholine: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

arachidonoylcholine : An acylcholine obtained by formal condensation of the carboxy group of arachidonic acid with the hydroxy group of choline. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID122198216
CHEBI ID133694
SCHEMBL ID22207934
MeSH IDM0408944

Synonyms (13)

Synonym
choline (5z,8z,11z,14z)-icosatetraenoate
2-{[(5z,8z,11z,14z)-icosa-5,8,11,14-tetraenoyl]oxy}-n,n,n-trimethylethan-1-aminium
choline (5z,8z,11z,14z)-eicosatetraenoate
CHEBI:133694
(5z,8z,11z,14z)-eicosatetraenoylcholine
(5z,8z,11z,14z)-icosatetraenoylcholine
choline (5z,8z,11z,14z)-icosa-5,8,11,14-tetraenoate
choline arachidonate
(5z,8z,11z,14z)-eicosa-5,8,11,14-tetraenoylcholine
(5z,8z,11z,14z)-icosa-5,8,11,14-tetraenoylcholine
choline (5z,8z,11z,14z)-eicosa-5,8,11,14-tetraenoate
arachidonoylcholine
SCHEMBL22207934
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
cholinergic agonistAny drug that binds to and activates cholinergic receptors.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
acylcholineA choline ester formed from choline and a carboxylic acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's2 (50.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]